Trial · NCT05377203
Registered outcomes22
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 22
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Mean systolic blood pressure of 24-hour | Four weeks | The reduction of mean systolic blood pressure of 24-hour in Ambulatory Blood Pressure Monitoring (ABPM) after 4 weeks of medication (from baseline). |
| Secondary | Mean systolic blood pressure of daytime and night | Four weeks | The reduction of mean systolic blood pressure of daytime and night in ABPM after 4 weeks of medication (from baseline). |
| Secondary | Mean diastolic blood pressure of 24-hour, daytime and night | Four weeks | The reduction of mean diastolic blood pressure of 24-hour, daytime and night in ABPM after 4 weeks of medication (from baseline). |
| Secondary | Morning blood pressure surge | Four weeks | The change of morning blood pressure surge in ABPM after 4 weeks of medication (from baseline). |
| Secondary | Office blood pressure | Four weeks | The reduction of office blood pressure after 4 weeks of medication (from baseline). |
| Secondary | Home blood pressure | Four weeks | The reduction of home blood pressure after 4 weeks of medication (from baseline). |
| Secondary | Heart rate | Four weeks | The change in heart rate after 4 weeks of medication (from baseline). |
| Secondary | Controlled rate of blood pressure | Four weeks | Controlled rate of blood pressure after 4 weeks of medication (from baseline). |
| Other | Percentage of participants with severe adverse events (SAE) | Four weeks | Percentage of participants with any SAE according to Good Clinical Practice definition. |
| Other | Percentage of participants with side effects | Four weeks | Percentage of participants with occurrence of any potentially relevant side effect (pre-specified as in study protocol). |
| Other | Rate of relevant side effects | Four weeks | Rate of relevant side effects (pre-specified as in study protocol) at the participant level. |
| Other | Mean change in serum potassium | Four weeks | Mean change (from baseline) in serum potassium after 4 weeks of medication. |
| Other | Mean change in serum sodium | Four weeks | Mean change (from baseline) in serum sodium after 4 weeks of medication. |
| Other | Mean change in blood urea nitrogen | Four weeks | Mean change (from baseline) in blood urea nitrogen after 4 weeks of medication. |
| Other | Mean change in serum creatinine | Four weeks | Mean change (from baseline) in serum creatinine after 4 weeks of medication. |
| Other | Mean change in serum uric acid | Four weeks | Mean change (from baseline) in serum uric acid after 4 weeks of medication. |
| Other | Mean change in serum glutamic-oxalacetic transaminase | Four weeks | Mean change (from baseline) in serum glutamic-oxalacetic transaminase after 4 weeks of medication. |
| Other | Mean change in serum glutamic-pyruvic transaminase | Four weeks | Mean change (from baseline) in serum glutamic-pyruvic transaminase after 4 weeks of medication. |
| Other | Mean change in serum bilirubin | Four weeks | Mean change (from baseline) in serum bilirubin (total and direct bilirubin) after 4 weeks of medication. |
| Other | Mean change in blood glucose | Four weeks | Mean change (from baseline) in blood glucose after 4 weeks of medication. |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT05377203/registered